Asthma and Community Health Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Ga.
Asthma and Community Health Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Ga.
J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1771-1777. doi: 10.1016/j.jaip.2019.02.016. Epub 2019 Apr 4.
Quality measures play a prominent role in the US health care system. They are used to monitor and report performance across health plans, providers, and health systems and are a foundational element of value-based payment. Measuring the quality of asthma care has been challenging because of a lack of reliable data to assess clinical processes and track patient-specific outcomes. Existing asthma Healthcare Effectiveness Data and Information Set measures rely on administrative claims-derived data on dispensed medications. These are proxy measures of appropriate prescribing but are not reflective of comprehensive asthma care. The increase in the volume and specificity of longitudinal clinical data in electronic health records, movement toward electronic quality measures, and advances in electronic clinical data systems enable the development of more meaningful measures. A patient-reported measure of asthma control would incorporate key clinical indicators such as a validated age- and culturally appropriate test, and would reflect the combined outcome of medical management, self-management education, reduction of environmental exposures, and appropriate support services. Although there is a current quality measure that includes a test of asthma control (the Optimal Asthma Control Measure), work is needed to address questions about usability, patient literacy, and the influence of setting on self-reported scores. Comprehensive reliability and validity testing of both clinical data and stratification across risk groups will be needed to determine whether a measure based on standardized assessments of asthma control indeed promote improved clinical outcomes.
质量措施在美国医疗保健系统中发挥着重要作用。它们用于监测和报告医疗计划、提供者和医疗系统的绩效,是基于价值的支付的基础要素。由于缺乏可靠的数据来评估临床流程和跟踪患者特定的结果,衡量哮喘护理的质量一直具有挑战性。现有的哮喘医疗保健效果数据和信息集措施依赖于行政索赔衍生的数据,用于分配药物。这些是适当处方的代理指标,但不能反映全面的哮喘护理。电子健康记录中纵向临床数据的数量和特异性增加,向电子质量措施的转变,以及电子临床数据系统的进步,使得开发更有意义的措施成为可能。哮喘控制的患者报告衡量标准将纳入关键临床指标,如经过验证的适合年龄和文化的测试,并将反映医疗管理、自我管理教育、减少环境暴露和适当支持服务的综合结果。虽然有一个当前的质量衡量标准包括哮喘控制测试(最佳哮喘控制衡量标准),但需要解决可用性、患者读写能力以及环境对自我报告分数的影响等问题。需要对临床数据和风险组分层进行全面的可靠性和有效性测试,以确定基于哮喘控制标准化评估的衡量标准是否确实能促进改善临床结果。